Jale KARAKAYA, Fulya KAYIKÇIOĞLU, Tuğba KINAY, Canan KÜÇÜK

Severe Preeclampsia versus HELLP Syndrome: Maternal and Perinatal Outcomes at <34 and >=34 Weeks' Gestation

Background: Preeclampsia and Hemolysis, Elevated Liver enzymes, Low Platelet (HELLP) syndrome are important disorders affecting the health of both the mother and fetus. Prediction of the maternal and peri-natal outcomes at early and late gestational age is im-portant for the management of both disorders.Aims: The purpose of the study was to investigate ad-verse maternal and perinatal outcomes in severe pre-eclampsia and HELLP syndrome cases according to gestational age.Study Design: Retrospective cross-sectional study.Methods: One hundred and ninety-seven pregnan-cies with severe preeclampsia and 56 pregnancies with HELLP syndrome were included the study. Clinical characteristics and adverse maternal and perinatal out-comes were noted from medical records. Participants were divided into two groups at =34 weeks' gestation:theseverepreeclampsiagroupandtheHELLP syndrome group. The differences between the outcomes in the groups were investigated. Statistical analysis was performed using the Student t test, Fisher Exact test and Yates' Chi-square test.Results: Eclampsia was more common in HELLP syn-drome cases at =34 weeks' gestation. The requirement for blood products transfusion was higher in the HELLP group at all gestational weeks. No statistical difference was found in perinatal outcomes between severe pre-eclampsia and HELLP groups at less than and more than 34 weeks' gestation.Conclusion: Eclampsia risk increases in HELLP syn-drome, especially at gestations less than 34 weeks. Perinatal morbidity at less than 34 weeks' gestation and mortality were similar in severe preeclampsia and HELLP syndrome cases at the same gestational age.Keywords: Blood transfusion, eclampsia, gestational

PDF

___

Steegers EAP, von Dadelszen P, Duvekott JJ, Pijnenborg R. Pre- eclampsia. Lancet 2010;376:631-44.
Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004;103:981-91.
Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986;155:501-9.
Sibai BM. The HELLP syndrome (hemolysis, elevated liver en- zymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 1990;162:311-6.
Martin JN Jr, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome. Am J Obstet Gynecol 1999;180:1373-84.
Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical util- ity of strict diagnostic criteria for the HELLP (hemolysis, el- evated liver enzymes and low platelets) syndrome. Am J Obstet Gynecol 1996;175:460-4.
Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM. Neonatal outcome in severe preeclamsia 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome matter? Am J Obstet Gy- necol 1999;180:221-5.
Haddad B, Barton JR, Livingston JC, Chahine R, Sibai B. HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome versus severe preeclampsia: Onset at _____=28.0 weeks'gestation. Am J Obstet Gynecol 2000;183:1475-9.
Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. American College of Obstetricians and Gynecolo- gists; Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122-31.
Martin JN Jr, Blake PG, Perry KG Jr, McCaul JF, Hess LW, Martin RW. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 1991;164:1500-9.
Martin JN Jr, Perry KG Jr, Miles JF Jr, Blake PG, Magann EF, Roberts WE, et al. The interrelationship of eclampsia, HELLP syndrome, and prematurity: cofactors for significant maternal and perinatal risk. Br J Obstet Gynaecol 1993;100:1095-100.
Anumba DO, Robson SC. Management of pre-eclampsia and haemolysis, elevated liver enzymes, and low platelets syndrome. Curr Opin Obstet Gynecol 1999;11:149-56.
Bombrys AE, Barton JR, Habli M, Sibai BM. Expectant man- agement of severe preeclampsia at 27(0/7) to 33(6/7) weeks' gestation: maternal and perinatal outcomes according to gesta- tional age by weeks at onset of expectant management. Am J Perinatol 2009;26:441-6.
Guzel AI, Kuyumcuoglu U, Celik Y. Are maternal and fetal parameters related to perinatal mortality in HELLP syndrome? Arch Gynecol Obstet 2011;283:1227-32.
Harms K, Rath W, Herting E, Kuhn W. Maternal hemolysis, el- evated liver enzymes, low platelet count and neonatal outcome. Am J Perinatol 1995;1:1-6.
Raval DS, Co S, Reid MA, Pildes R. Maternal and neonatal out- come of pregnancies complicated with maternal HELLP syn- drome. J Perinatol 1997;17:266-9.
Turgut A, Demirci O, Demirci E, Uludoğan M. Comparison of maternal and neonatal outcomes in women with HELLP syn- drome and women with severe preeclampsia without HELLP syndrome. J Prenat Med 2010;4:51-8.
Gulec UK, Ozgunen FT, Guzel AB, Buyukkurt S, Seydaoglu G, Demir SC. Clinical course and complications of HELLP syndrome according to time of onset. Clin Exp Obstet Gynecol 2012;39:500-3.
Osmanağaoğlu MA, Erdoğan I, Zengin U, Bozkaya H. Com- parison between HELLP syndrome, chronic hypertension, and superimposed preeclampsia on chronic hypertension without HELLP syndrome. J Perinat Med 2004;32:481-5.
Gul A, Cebeci A, Aslan H, Polat I, Ozdemir A, Ceylan Y. Perina- tal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome. Gynecol Obstet Invest 2005;59:113-8.